An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
After years of rising obesity rates in the US, the numbers dipped slightly during 2023, though experts disagree about the ...
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...
Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking ...
The effects that a pause may have on your body may depend on why you're taking the medication in the first place.
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
GLP-1 class drugs like Zepbound and Mounjaro form part of a larger group of products like Wegovy and Ozempic from Novo ...
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
U.S. Enters a New Political Era, Defined by Donald Trump The presidential race in 2012 ended a pattern in U.S. politics, which has since become characterized by Mr. Trump’s populism, a Times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback